-
Product Insights
Anthrax - Drugs In Development, 2024
Empower your strategies with our Anthrax – Drugs In Development, 2024 report and make more profitable business decisions. Anthrax is a serious infectious disease caused by Bacillus anthracis. Signs and symptoms include nausea, vomiting, abdominal pain, headache, loss of appetite, fever, severe bloody diarrhea in the later stages of the disease, sore throat, and difficulty swallowing. Risk factors include illegal intravenous drug use, exposure to animal skins, and working in veterinary medicine, especially dealing with livestock. The Anthrax drugs in development...
-
Product Insights
Chagas Disease (American Trypanosomiasis) - Drugs In Development, 2024
Empower your strategies with our Chagas Disease (American Trypanosomiasis) – Drugs In Development, 2024 report and make more profitable business decisions. Chagas disease, or American trypanosomiasis is a vector-borne anthropozoonosis caused by the protozoan parasite Trypanosoma cruzi. Symptoms include swelling at the infection site, fever, fatigue, body aches, loss of appetite, nausea, diarrhea or vomiting, and swollen glands. Treatment includes antiparasitic medications. The Chagas Disease (American Trypanosomiasis) drugs in development market research report provide comprehensive information on the therapeutics under development...
-
Product Insights
Genital Warts (Condylomata Acuminata) - Drugs In Development, 2024
Empower your strategies with our Genital Warts (Condylomata Acuminata) – Drugs In Development, 2024 report and make more profitable business decisions. Genital warts (condyloma acuminatum) are a sexually transmitted infection caused by the human papillomavirus (HPV) types 6 and 11. It is spread by skin-to-skin contact, usually during sex. The warts present in clusters or separately and can be found in the genital or anal area. Genital warts are typically painless but can cause itching, discomfort, or bleeding. Treatments may include...
-
Product Insights
Pulmonary Tuberculosis - Drugs In Development, 2024
Empower your strategies with our Pulmonary Tuberculosis – Drugs In Development, 2024 report and make more profitable business decisions. Pulmonary tuberculosis (TB) is an infectious respiratory disease caused by Mycobacterium tuberculosis, capable of spreading to other organs. The bacterium is highly contagious, transmitted through air droplets from coughs or sneezes of infected individuals. Initial infection, known as primary TB, may be asymptomatic. When symptoms manifest, they encompass breathing difficulties, chest pain, cough with mucus, blood-tinged sputum, night sweats, fatigue, fever, weight...
-
Product Insights
Monkeypox - Drugs In Development, 2024
Empower your strategies with our Monkeypox – Drugs In Development, 2024 report and make more profitable business decisions. Mpox, caused by the monkeypox virus, is an infectious disease presenting with a painful rash, fever, and enlarged lymph nodes. While most individuals fully recover, some may experience severe illness. Person-to-person transmission occurs through direct contact with infectious skin or lesions, including those in the mouth or genitals. Symptoms manifest from 1-21 days after exposure, lasting 2-4 weeks or longer in individuals with...
-
Product Insights
Rotavirus Infections - Drugs In Development, 2024
Empower your strategies with our Rotavirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Rotavirus is a virus that infects the bowels. Rotavirus is the most common cause of severe diarrhea among infants and children. Transmission of rotavirus most often occurs through fecal-oral contact. Usually, this occurs from poor hand washing or from ingestion of contaminated food or water. The virus may also be transmitted through the respiratory tract or by other body fluids, but these...
-
Product Insights
Bacillary Dysentery (Shigellosis) - Drugs In Development, 2024
Empower your strategies with our Bacillary Dysentery (Shigellosis) – Drugs In Development, 2024 report and make more profitable business decisions. Shigella infection (shigellosis) is an intestinal disease caused by bacteria known as shigella. Symptoms include diarrhea, abdominal cramps, and fever. Predisposing factors include eating contaminated food, age, international travel, and being a homosexual man. Treatment includes antibiotics. The Bacillary Dysentery (Shigellosis) drugs in development market research report provide comprehensive information on the therapeutics under development for Bacillary Dysentery (Shigellosis), complete with...
-
Product Insights
Meningitis - Drugs In Development, 2024
Empower your strategies with our Meningitis – Drugs In Development, 2024 report and make more profitable business decisions. Meningitis is the inflammation of the meninges, protective membranes covering the brain and spinal cord. The cause of inflammation can be infection by viruses, bacteria, or other microorganisms, and less commonly by certain drugs. As the inflammation is in proximity to the brain and spinal cord, meningitis can be life-threatening, depending on its cause. Viral meningitis is not life-threatening; those affected can be...
-
Product Insights
Influenza A Virus, H7N9 Subtype Infections - Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H7N9 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. Avian influenza A (H7N9) is a subtype of influenza viruses known as "bird flu". This infection is seen both in humans and birds. Infection is caused when a person is exposure to infected poultry or contaminated environments. Symptoms include fever, cough that produces sputum, headache, myalgia, and general malaise. Treatment includes antiviral drugs. The Influenza A Virus, H7N9...
-
Product Insights
Typhoid Fever - Drugs In Development, 2024
Empower your strategies with our Typhoid Fever – Drugs In Development, 2024 report and make more profitable business decisions. Typhoid fever is an infection that causes diarrhea and a rash. It is most commonly due to a type of bacterium called Salmonella typhi. Symptoms include abdominal tenderness, agitation, chills, delirium, hallucinations, severe fatigue, and weakness. Treatment includes antibiotics and supportive therapy. The Typhoid Fever drugs in development market research report provide comprehensive information on the therapeutics under development for Typhoid Fever,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.